{"id":331503,"date":"2026-10-29T11:45:24","date_gmt":"2026-10-29T06:15:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=331503"},"modified":"2026-10-29T11:45:24","modified_gmt":"2026-10-29T06:15:24","slug":"midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Public Holding Below 10 Per Cent Stocks to Watch for Future Multibagger Potential: Lupin, Max Healthcare, Dabur and Uno Minda"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Lupin Rs 1,972.70. Max Healthcare Rs 851.50. Dabur Rs 360. Uno Minda Rs 1,099.90. Market caps from Rs 65,925 crore to Rs 91,955 crore. Data as of 28 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Lupin, Max Healthcare, Dabur and Uno Minda are the 4 picks in this public holding below 10 per cent stocks watchlist, with market caps between Rs 65,925 crore and Rs 91,955 crore. Lupin stands out for the highest return on equity at 23.76%, while Max Healthcare offers 18.82% revenue growth in FY26. PE ratios run from 16.57 to 59.66, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.<\/p>\n<\/p><\/div>\n<p>Public holding below 10 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Lupin, Max Healthcare, Dabur and Uno Minda meet that test, with market caps from Rs 65,925 crore to Rs 91,955 crore and Lupin offering the highest return on equity at 23.76%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and public shareholding below 10 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and public shareholding below 10 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening public holding below 10 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=public-holding-below-per-cent-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#What_Are_Public_Holding_Below_10_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Public Holding Below 10 Per Cent Stocks and Why Do They Attract Multibagger Interest?\">What Are Public Holding Below 10 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Public_Holding_Below_10_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Public Holding Below 10 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE\">Public Holding Below 10 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Lupin_Revenue_Up_2676_in_FY26\" title=\"Lupin: Revenue Up 26.76% in FY26\">Lupin: Revenue Up 26.76% in FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Max_Healthcare_2426_Profit_CAGR_Since_FY22\" title=\"Max Healthcare: 24.26% Profit CAGR Since FY22\">Max Healthcare: 24.26% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Dabur_Profit_Compounding_at_177_a_Year\" title=\"Dabur: Profit Compounding at 1.77% a Year\">Dabur: Profit Compounding at 1.77% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Uno_Minda_3865_Profit_CAGR_Since_FY22\" title=\"Uno Minda: 38.65% Profit CAGR Since FY22\">Uno Minda: 38.65% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Public_Holding_Below_10_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Public Holding Below 10 Per Cent Stocks: Financial Comparison on Growth and Margins\">Public Holding Below 10 Per Cent Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\" title=\"Institutional Holding in Lupin, Max Healthcare, Dabur and Uno Minda\">Institutional Holding in Lupin, Max Healthcare, Dabur and Uno Minda<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Public_Holding_Below_10_Per_Cent_Stocks\" title=\"Risks to Weigh in Public Holding Below 10 Per Cent Stocks\">Risks to Weigh in Public Holding Below 10 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Public_Holding_Below_10_Per_Cent_Stocks\" title=\"How to Choose Between Public Holding Below 10 Per Cent Stocks\">How to Choose Between Public Holding Below 10 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Public_Holding_Below_10_Per_Cent_Stocks_to_Watch\" title=\"Frequently Asked Questions on Public Holding Below 10 Per Cent Stocks to Watch\">Frequently Asked Questions on Public Holding Below 10 Per Cent Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Which_are_the_best_public_holding_below_10_per_cent_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best public holding below 10 per cent stocks to watch for multibagger potential?\">Which are the best public holding below 10 per cent stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Is_Lupin_a_good_stock_for_long-term_investors\" title=\"Is Lupin a good stock for long-term investors?\">Is Lupin a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Can_Uno_Minda_become_a_multibagger_from_here\" title=\"Can Uno Minda become a multibagger from here?\">Can Uno Minda become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\" title=\"What is the market cap of Lupin, Max Healthcare, Dabur and Uno Minda?\">What is the market cap of Lupin, Max Healthcare, Dabur and Uno Minda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_public_holding_below_10_per_cent_stocks\" title=\"What are the risks of investing in public holding below 10 per cent stocks?\">What are the risks of investing in public holding below 10 per cent stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#Why_is_Uno_Minda_trading_at_a_PE_of_5108\" title=\"Why is Uno Minda trading at a PE of 51.08?\">Why is Uno Minda trading at a PE of 51.08?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-public-holding-below-10-per-cent-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\" title=\"How much do institutions hold in Lupin, Max Healthcare, Dabur and Uno Minda?\">How much do institutions hold in Lupin, Max Healthcare, Dabur and Uno Minda?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Public_Holding_Below_10_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Public Holding Below 10 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Public holding below 10 per cent stocks are shares in which retail and other non-institutional investors own less than a tenth of the company, with promoters and institutions holding the rest. The four here cover pharmaceuticals, hospitals, auto components and household products.<\/p>\n<p>A small public float usually means that serious long term holders such as promoters and institutions own most of the company, which supports stability. For public holding below 10 per cent stocks, both FY26 and the latest quarter showed growth. For public holding below 10 per cent stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of public holding below 10 per cent stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for public holding below 10 per cent stocks before you decide.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Public_Holding_Below_10_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Public Holding Below 10 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 28 October 2026. Lupin combines the lowest PE of the group, 16.57, with the highest return on equity, 23.76%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,972.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">91,955<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.57<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.29<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,900.00 to 2,529.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\">Max Healthcare Institute<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">851.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">86,925<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">815.00 to 1,221.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dabur\/dabur-india-ltd-share-price-today\">Dabur India<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">360<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">67,255<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.56<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.11<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">357.80 to 534.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unominda\/uno-minda-ltd-share-price-today\">Uno Minda<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,099.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">65,925<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">51.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.22<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">994.00 to 1,355.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Lupin_Revenue_Up_2676_in_FY26\"><\/span><strong>Lupin: Revenue Up 26.76% in FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lupin is a global pharmaceutical company with a large presence in the United States, India and other markets across generics, branded drugs and respiratory products. It reported FY26 revenue of Rs 29,038.95 crore, up 26.76% year on year, and net profit of Rs 5,355.47 crore, up 61.98%. Revenue has compounded at 14.98% a year since FY22. Operating margin was 31.06% in FY26. The debt-to-equity ratio is 0.29.<\/p>\n<p>In the June 2026 quarter, revenue rose 32.45% to Rs 8,407.21 crore and net profit grew 16.01% to Rs 1,416.98 crore. The share price has gained 111.00% over five years. Foreign investors raised their holding from 21.25% in June 2025 to 22.42% in June 2026. The stock trades at a PE of 16.57 against an industry PE of 36.42, below the sector average, with a return on equity of 23.76%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Max_Healthcare_2426_Profit_CAGR_Since_FY22\"><\/span><strong>Max Healthcare: 24.26% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.<\/p>\n<p>The stock trades at a PE of 59.66 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%. In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dabur_Profit_Compounding_at_177_a_Year\"><\/span><strong>Dabur: Profit Compounding at 1.77% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dabur India is a leading Ayurveda and natural health care company with brands in hair care, oral care, juices and health supplements. It reported FY26 revenue of Rs 13,792.34 crore, up 5.18% year on year, and net profit of Rs 1,868.69 crore, up 7.37%. Revenue has compounded at 5.15% a year since FY22. Operating margin was 23.00% in FY26. The debt-to-equity ratio is 0.11, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 10.95% to Rs 3,936.95 crore and net profit grew 15.32% to Rs 586.16 crore. Domestic institutions raised their holding from 16.24% in June 2025 to 18.72% in June 2026. The stock trades at a PE of 34.56 against an industry PE of 34.68, below the sector average, with a return on equity of 16.59%. The dividend yield is 2.18%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Uno_Minda_3865_Profit_CAGR_Since_FY22\"><\/span><strong>Uno Minda: 38.65% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uno Minda makes switches, lighting, sensors and safety components for two-wheeler, passenger and commercial vehicle makers. It reported FY26 revenue of Rs 19,692.02 crore, up 17.19% year on year, and net profit of Rs 1,284.06 crore, up 25.82%. Net profit has compounded at 38.65% a year since FY22, while revenue has grown 23.83% a year. Operating margin was 12.75% in FY26. The debt-to-equity ratio is 0.40.<\/p>\n<p>The stock trades at a PE of 51.08 against an industry PE of 37.22, with a return on equity of 17.53%. In the June 2026 quarter, revenue rose 23.60% to Rs 5,563.16 crore and net profit grew 2.10% to Rs 315.51 crore. The share price has gained 187.71% over five years. Domestic institutions raised their holding from 15.85% in June 2025 to 17.53% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Public_Holding_Below_10_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Public Holding Below 10 Per Cent Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these public holding below 10 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lupin<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29,038.95<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,355.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.98%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.45%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.40%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,536.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,442.41<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.00%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dabur<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13,792.34<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,868.69<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19,692.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,284.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.26%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these public holding below 10 per cent stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\"><\/span><strong>Institutional Holding in Lupin, Max Healthcare, Dabur and Uno Minda<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these public holding below 10 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Max Healthcare has the deepest institutional backing, with FII and DII together holding 71.74% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%), Dabur (from 16.24% to 18.72%) and Uno Minda (from 15.85% to 17.53%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lupin<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.85%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.65%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">41.78%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dabur<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">66.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.72%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.37%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Public_Holding_Below_10_Per_Cent_Stocks\"><\/span><strong>Risks to Weigh in Public Holding Below 10 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with public holding below 10 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Uno Minda trades at a PE of 51.08 against an industry PE of 37.22, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Public_Holding_Below_10_Per_Cent_Stocks\"><\/span><strong>How to Choose Between Public Holding Below 10 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from public holding below 10 per cent stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (34.68 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Lupin, Max Healthcare, Dabur and Uno Minda live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among public holding below 10 per cent stocks, Lupin stands out for the highest return on equity at 23.76%, Max Healthcare for 18.82% revenue growth in FY26, Dabur for 5.18% revenue growth in FY26 and Uno Minda for the fastest profit growth, 38.65% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing public holding below 10 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Public_Holding_Below_10_Per_Cent_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Public Holding Below 10 Per Cent Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_public_holding_below_10_per_cent_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best public holding below 10 per cent stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lupin, Max Healthcare, Dabur and Uno Minda are the 4 names this list highlights, with market caps of Rs 91,955 crore, Rs 86,925 crore, Rs 67,255 crore and Rs 65,925 crore respectively. Lupin is notable for the highest return on equity at 23.76%. Max Healthcare stands out for 18.82% revenue growth in FY26. Dabur offers 5.18% revenue growth in FY26. Uno Minda brings the fastest profit growth, 38.65% a year since FY22. These are watchlist names for public holding below 10 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Lupin_a_good_stock_for_long-term_investors\"><\/span><strong>Is Lupin a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lupin has a return on equity of 23.76%, a PE of 16.57 against an industry PE of 36.42 and a market cap of Rs 91,955 crore. FY26 revenue rose 26.76%, and June 2026 quarter net profit grew 16.01%. Long-term returns in public holding below 10 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Uno_Minda_become_a_multibagger_from_here\"><\/span><strong>Can Uno Minda become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in public holding below 10 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 51.08 against an industry PE of 37.22, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\"><\/span><strong>What is the market cap of Lupin, Max Healthcare, Dabur and Uno Minda?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 28 October 2026, Lupin has a market cap of Rs 91,955 crore, Max Healthcare has a market cap of Rs 86,925 crore, Dabur has a market cap of Rs 67,255 crore and Uno Minda has a market cap of Rs 65,925 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on public holding below 10 per cent stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_public_holding_below_10_per_cent_stocks\"><\/span><strong>What are the risks of investing in public holding below 10 per cent stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Uno Minda trades at a PE of 51.08 against an industry PE of 37.22, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Uno_Minda_trading_at_a_PE_of_5108\"><\/span><strong>Why is Uno Minda trading at a PE of 51.08?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uno Minda&#8217;s PE of 51.08 compares with an industry PE of 37.22. The market is paying a premium for a return on equity of 17.53%, profit growth of 38.65% a year since FY22 and FY26 revenue growth of 17.19%, which also means the stock is more sensitive if growth slows. Investors in public holding below 10 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Lupin_Max_Healthcare_Dabur_and_Uno_Minda\"><\/span><strong>How much do institutions hold in Lupin, Max Healthcare, Dabur and Uno Minda?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 47.07% of Lupin (22.42% and 24.65%), 71.74% of Max Healthcare (41.78% and 29.96%), 28.38% of Dabur (9.66% and 18.72%) and 25.68% of Uno Minda (8.15% and 17.53%). Rising institutional holding is a useful signal in public holding below 10 per cent stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best public holding below 10 per cent stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lupin, Max Healthcare, Dabur and Uno Minda are the 4 names this list highlights, with market caps of Rs 91,955 crore, Rs 86,925 crore, Rs 67,255 crore and Rs 65,925 crore respectively. Lupin is notable for the highest return on equity at 23.76%. Max Healthcare stands out for 18.82% revenue growth in FY26. Dabur offers 5.18% revenue growth in FY26. Uno Minda brings the fastest profit growth, 38.65% a year since FY22. These are watchlist names for public holding below 10 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Lupin a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lupin has a return on equity of 23.76%, a PE of 16.57 against an industry PE of 36.42 and a market cap of Rs 91,955 crore. FY26 revenue rose 26.76%, and June 2026 quarter net profit grew 16.01%. Long-term returns in public holding below 10 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Uno Minda become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in public holding below 10 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 51.08 against an industry PE of 37.22, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Lupin, Max Healthcare, Dabur and Uno Minda?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 28 October 2026, Lupin has a market cap of Rs 91,955 crore, Max Healthcare has a market cap of Rs 86,925 crore, Dabur has a market cap of Rs 67,255 crore and Uno Minda has a market cap of Rs 65,925 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on public holding below 10 per cent stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in public holding below 10 per cent stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Uno Minda trades at a PE of 51.08 against an industry PE of 37.22, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Uno Minda trading at a PE of 51.08?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Uno Minda's PE of 51.08 compares with an industry PE of 37.22. The market is paying a premium for a return on equity of 17.53%, profit growth of 38.65% a year since FY22 and FY26 revenue growth of 17.19%, which also means the stock is more sensitive if growth slows. Investors in public holding below 10 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Lupin, Max Healthcare, Dabur and Uno Minda?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 47.07% of Lupin (22.42% and 24.65%), 71.74% of Max Healthcare (41.78% and 29.96%), 28.38% of Dabur (9.66% and 18.72%) and 25.68% of Uno Minda (8.15% and 17.53%). Rising institutional holding is a useful signal in public holding below 10 per cent stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap public holding below 10 per cent stocks compared on market cap, PE, ROE, growth and institutional holding: Lupin, Max Healthcare, Dabur and Uno Minda.<\/p>\n","protected":false},"author":33,"featured_media":331502,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[17684,17683],"class_list":["post-331503","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-public-holding-below-10-per-cent-sector","tag-public-holding-below-10-per-cent-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["331502"],"rank_math_title":["Public Holding Below 10 Per Cent Stocks to Watch in 2026"],"rank_math_description":["Public holding below 10 per cent stocks to watch for multibagger potential: Lupin, Max Healthcare, Dabur and Uno Minda. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["public holding below 10 per cent stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-public-holding-below-10-per-cent-stocks-to-watch-for-future-multibagger.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=331503"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331503\/revisions"}],"predecessor-version":[{"id":331504,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331503\/revisions\/331504"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/331502"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=331503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=331503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=331503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}